{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06339008",
            "orgStudyIdInfo": {
                "id": "18789"
            },
            "secondaryIdInfos": [
                {
                    "id": "J2T-MC-KGBT",
                    "type": "OTHER",
                    "domain": "Eli Lilly and Company"
                },
                {
                    "id": "2023-508817-18-00",
                    "type": "OTHER",
                    "domain": "EU Clinical Trial Number"
                }
            ],
            "organization": {
                "fullName": "Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)",
            "officialTitle": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-lebrikizumab-in-adult-participants-with-perennial-allergic-rhinitis-prepared"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-25",
            "studyFirstSubmitQcDate": "2024-03-25",
            "studyFirstPostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Eli Lilly and Company",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. The study will last about 18 months"
        },
        "conditionsModule": {
            "conditions": [
                "Perennial Allergic Rhinitis (PAR)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 450,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Lebrikizumab every 2 weeks (Q2W)/ every 4 weeks (Q4W)",
                    "type": "EXPERIMENTAL",
                    "description": "Lebrikizumab will be given as a subcutaneous (SC) injection. Participants will receive background therapy with intranasal corticosteroids (INCS).",
                    "interventionNames": [
                        "Drug: LY3650150",
                        "Drug: Standard therapy for INCS"
                    ]
                },
                {
                    "label": "Lebrikizumab Q2W/every 8 weeks (Q8W)",
                    "type": "EXPERIMENTAL",
                    "description": "Lebrikizumab will be given as an SC injection. Participants will receive background therapy with INCS.",
                    "interventionNames": [
                        "Drug: LY3650150",
                        "Drug: Standard therapy for INCS"
                    ]
                },
                {
                    "label": "Placebo Q2W/Q4W",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo matching Lebrikizumab will be given as an SC injection. Participants will receive background therapy with INCS.",
                    "interventionNames": [
                        "Drug: Placebo",
                        "Drug: Standard therapy for INCS"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "LY3650150",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "Lebrikizumab Q2W/every 8 weeks (Q8W)",
                        "Lebrikizumab every 2 weeks (Q2W)/ every 4 weeks (Q4W)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Administered SC",
                    "armGroupLabels": [
                        "Placebo Q2W/Q4W"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Standard therapy for INCS",
                    "description": "Administered as intranasal spray",
                    "armGroupLabels": [
                        "Lebrikizumab Q2W/every 8 weeks (Q8W)",
                        "Lebrikizumab every 2 weeks (Q2W)/ every 4 weeks (Q4W)",
                        "Placebo Q2W/Q4W"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean Change From Baseline (CFBL) in Total Nasal Symptom Score (TNSS) at week 16",
                    "description": "Total nasal symptom score was a composite of 4 symptoms (rhinorrhea, nasal congestion, nasal itching and sneezing), each symptom was scored on a scale of 0 = none, 1 = mild, 2 = moderate, 3 = severe. The total score ranged from 0 to 12. The higher the score was, the more severe the symptoms were.",
                    "timeFrame": "Baseline, Week 16"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean CFBL in Rhinoconjunctivitis Quality of Life Questionnaire Standardized Version [RQLQ(S)] at week 16",
                    "description": "The RQLQ includes 28 questions (completed between 10-15 min). Participants are asked to recall their experiences during the previous week and to respond to each question on a 7-point scale. The RQLQ score ranges from 0 to 6 (0 = no impairment, 6 = severe impairment).",
                    "timeFrame": "Baseline, Week 16"
                },
                {
                    "measure": "Mean CFBL in RQLQ(S) at week 56",
                    "description": "The RQLQ includes 28 questions (completed between 10-15 min). Participants are asked to recall their experiences during the previous week and to respond to each question on a 7-point scale. The RQLQ score ranges from 0 to 6 (0 = no impairment, 6 = severe impairment)",
                    "timeFrame": "Baseline, Week 56"
                },
                {
                    "measure": "Mean CFBL in TNSS at Week 4",
                    "description": "Total nasal symptom score was a composite of 4 symptoms (rhinorrhea, nasal congestion, nasal itching and sneezing), each symptom was scored on a scale of 0 = none, 1 = mild, 2 = moderate, 3 = severe. The total score ranged from 0 to 12. The higher the score was, the more severe the symptoms were.",
                    "timeFrame": "Baseline, Week 4"
                },
                {
                    "measure": "Mean CFBL in TNSS at Week 56",
                    "description": "Total nasal symptom score was a composite of 4 symptoms (rhinorrhea, nasal congestion, nasal itching and sneezing), each symptom was scored on a scale of 0 = none, 1 = mild, 2 = moderate, 3 = severe. The total score ranged from 0 to 12. The higher the score was, the more severe the symptoms were.",
                    "timeFrame": "Baseline, Week 56"
                },
                {
                    "measure": "Mean CFBL in Postnasal drip score at Week 16",
                    "description": "Postnasal drip is mucus drainage down the throat, as part of their Allergic Rhinitis (AR), will be rated by participants using a 4-point scale, where 0 corresponds to no symptoms and 3 corresponds to severe symptoms. Study participants are asked to record the severity of their postnasal drip, at its worst, for the previous 24 hours.",
                    "timeFrame": "Baseline, Week 16"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Physician-diagnosed PAR.\n* Has a positive skin prick test (SPT) with indoor allergens and/or positive antigen-specific serum immunoglobulin E (IgE) for indoor allergens \u22650.70 kU/L, utilizing a validated assay (central laboratory).\n* A dermatographic participant who has a known history of dermatographism or identified during the SPT may participate in this study with a positive serum IgE test.\n* Participants who have concomitant asthma must be stable in the 3 months prior to screening using permitted regular asthma treatment.\n\nExclusion Criteria:\n\n* Have received a dose of lebrikizumab.\n* Is currently on allergen immunotherapy. However, individuals who discontinued subcutaneous or sublingual immunotherapy (SCIT/SLIT) for \u22653 years prior to randomization are eligible, if they were not on a maintenance allergen immunotherapy (AIT) regimen.\n* Have received treatment with any rescue medication during the screening and/or run-in period.\n* Have received treatment with any biologic or systemic immunosuppressants for inflammatory disease or autoimmune disease prior to the baseline visit:\n\n  1. B cell-depleting biologics, including rituximab, within 6 months.\n  2. other biologics within 5 half-lives (if known) or 8 weeks, whichever is longer.\n  3. Systemic immunosuppressants within 4 weeks prior to baseline.\n* Have a history of seasonal worsening of AR and if the seasonal worsening is expected during the 4-week run-in period, the first 16 weeks after randomization, or during the last 4 weeks of the maintenance period.\n* Anticipates significant changes in their daily environmental exposure\n* Has a known history of recurrent acute or chronic sinusitis,\n* Female participant who is pregnant, breastfeeding or is planning to become pregnant or to breastfeed during the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "There may be multiple sites in this clinical trial 1-877-CTLILLY (1-877-285-4559) or",
                    "role": "CONTACT",
                    "phone": "1-317-615-4559",
                    "email": "ClinicalTrials.gov@lilly.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)",
                    "affiliation": "Eli Lilly and Company",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Southern California Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "California City",
                    "state": "California",
                    "zip": "92691",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "949-276-4917"
                        },
                        {
                            "name": "Warner Carr",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.1258,
                        "lon": -117.9859
                    }
                },
                {
                    "facility": "310 Clinical Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Inglewood",
                    "state": "California",
                    "zip": "90301",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "310-878-2636"
                        },
                        {
                            "name": "Soheil Hekmat",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.96168,
                        "lon": -118.35313
                    }
                },
                {
                    "facility": "Allergy and Asthma",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "858-268-2368",
                            "phoneExt": "143"
                        },
                        {
                            "name": "Bob Geng",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Asthma and Allergy Associates, PC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Colorado Springs",
                    "state": "Colorado",
                    "zip": "80907-6231",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "719-473-8330 x5"
                        },
                        {
                            "name": "Luke Webb",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.83388,
                        "lon": -104.82136
                    }
                },
                {
                    "facility": "Florida Center For Allergy & Asthma Care Aventura",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Aventura",
                    "state": "Florida",
                    "zip": "33180",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "305-931-7583"
                        },
                        {
                            "name": "Jaime Landman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.95648,
                        "lon": -80.13921
                    }
                },
                {
                    "facility": "Bluegrass Allergy Research",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40509",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "859-303-7191"
                        },
                        {
                            "name": "William Greisner",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "Respiratory Medicine Research Institute of Michigan, PLC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ypsilanti",
                    "state": "Michigan",
                    "zip": "48197",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "734-528-0477"
                        },
                        {
                            "name": "Jeffrey Leflein",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.24115,
                        "lon": -83.61299
                    }
                },
                {
                    "facility": "Clinical Research Institute",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55402",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "612-333-2200",
                            "phoneExt": "378"
                        },
                        {
                            "name": "Gary Berman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "Allergy and Asthma Consultants",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63141",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "314-991-5117"
                        },
                        {
                            "name": "Robert Onder",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Dr. Patrick Perin",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Teaneck",
                    "state": "New Jersey",
                    "zip": "07666",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patrick Perin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.8976,
                        "lon": -74.01597
                    }
                },
                {
                    "facility": "Smith Allergy and Asthma",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ithaca",
                    "state": "New York",
                    "zip": "14845",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "607-463-2223"
                        },
                        {
                            "name": "Christopher Smith",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.44063,
                        "lon": -76.49661
                    }
                },
                {
                    "facility": "Bernstein Clinical Research Center, LLC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45236",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "314-991-5117"
                        },
                        {
                            "name": "David Bernstein",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Northwest Research Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97202",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "503-238-6233"
                        },
                        {
                            "name": "Anthony Montanaro",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Allergy and Clinical Immunology Associates",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15241",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "412-833-4051",
                            "phoneExt": "116"
                        },
                        {
                            "name": "Michael Palumbo",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "AARA Research Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75231",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "214-365-0365"
                        },
                        {
                            "name": "W LUMRY",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Kerrville Allergy and Asthma Associates",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Kerrville",
                    "state": "Texas",
                    "zip": "78028",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "830-896-1433"
                        },
                        {
                            "name": "Dale Mohar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.04743,
                        "lon": -99.14032
                    }
                },
                {
                    "facility": "Allergy Asthma Research Institute",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Waco",
                    "state": "Texas",
                    "zip": "76712",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "254-741-8151"
                        },
                        {
                            "name": "Niran Amar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.54933,
                        "lon": -97.14667
                    }
                },
                {
                    "facility": "Allergy, Asthma & Sinus Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Greenfield",
                    "state": "Wisconsin",
                    "zip": "53228",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "414-529-8519"
                        },
                        {
                            "name": "Gary Steven",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.9614,
                        "lon": -88.01259
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Anonymized individual participant level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "Data are available 6 months after the primary publication and approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.",
            "accessCriteria": "A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement",
            "url": "http://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012220",
                    "term": "Rhinitis"
                },
                {
                    "id": "D000065631",
                    "term": "Rhinitis, Allergic"
                },
                {
                    "id": "D000012221",
                    "term": "Rhinitis, Allergic, Perennial"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000009668",
                    "term": "Nose Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                },
                {
                    "id": "D000012130",
                    "term": "Respiratory Hypersensitivity"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15049",
                    "name": "Rhinitis",
                    "asFound": "Rhinitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30545",
                    "name": "Rhinitis, Allergic",
                    "asFound": "Allergic Rhinitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15050",
                    "name": "Rhinitis, Allergic, Perennial",
                    "asFound": "Perennial Allergic Rhinitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M12604",
                    "name": "Nose Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M14967",
                    "name": "Respiratory Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}